Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation

Transfusion

Volumn 38, Issue 4, 1998, Pages 385-391

  Perez Simon J A ^a   Caballero, M D ^a   Corral, M ^a   Nieto, M J ^a   Orfao, A ^a   Vazquez, L ^a   Amigo, M L ^a   Berges, C ^a   Gonzalez M ^a   Del Canizo C ^a   San Miguel, J F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; CANCER PATIENT; CLINICAL TRIAL; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL;

EID: 0344783931     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38498257378.x     Document Type: Article

References (28)

1. Arnold R, Schmeiser T, Heit W, et al. Hemopoietic reconstitution after bone marrow transplantation. Exp Hematol 1986;14:271-7.
2. To LB, Roberts MM, Haylock DN, et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992;9:277-84.
3. Bacigalupo A, Piaggio G, Podesta M, et al. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995;15:221-6.
4. Torres A, Alonso MC, Gomez-Villagran JL, et al. No influence of number of donor CFU-GM on granulocyte recovery in bone marrow transplantation for acute leukemia. Blut 1985;50:89-94.
5. Atkinson K, Norrie S, Chan P, et al. Lack of correlation between nucleated bone marrow cell dose, marrow CFU-GM dose or marrow CFU-E dose and the rate of HLA-identical sibling marrow engraftment. Br J Haematol 1985;60:245-51.
6. Möhle R, Murea S, Pförsich M, et al. Estimation of the progenitor cell yield in a leukapheresis product by previous measurement of CD34+ cells in the peripheral blood. Vox Sang 1996;71:90-6.
7. 8/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation. Exp Hematol 1995;23:1581-8.
8. Elliott C, Samson DM, Armitage S, et al. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration cell in peripheral blood. J Clin Oncol 1996;14:970-3.
9. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood 1996;87:1-13.
10. Siena S, Bregni M, Gianni M. Estimation of peripheral blood CD34 + cells for autologous transplantation in cancer patients (letter). Exp Hematol 1993;21:203-5.
11. Iscove NN, Senn JS, Till JE, McCulloch EA. Colony formation by normal and leukemic human marrow cells in culture: effect of conditioned medium from human leukocytes. Blood 1971;37:1-5.
12. Minden MD, Till JE, McCulloch EA. Proliferative state of blast cell progenitors in acute myeloblastic leukemia (AML). Blood 1978;52:592-600.
13. Macedo A, Orfao A, Ciudad J, et al. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease. Leukemia 1995;9:1896-901.
14. Bender JG, Unverzagt K, Walker D. Guidelines for determination of CD34 cells by flow cytometry: application to the harvesting and transplantation of peripheral blood stem cells. In: Wunder E, Sovalat H, Henon R, Serke S, eds. Hematopoietic stem cells: the Mulhouse Manual. Dayton, OH: AlphaMed Press, 1994: 31-41.
15. Säuberlich S, Kirsch A, Serke S. Determination of CD34+ hematopoietic cells by multiparameter flow cytometry: technical remarks. In: Wunder E, Sovalat H, Henon R, Serke S, eds. Hematopoietic stem cells: the Mulhouse Manual. Dayton, OH: AlphaMed Press, 1994:45-60.
16. Mavroudis D, Read E, Cottler-Fox M, et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996;88:3223-9.
17. Tricot G, Jagannath S, Vesole D, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995;85:588-96.
18. Torretta L, Perotti C, Dornini G, et al. Circulating progenitor cell collection: experience from 275 leukaphereses in various malignancies and in healthy donors. Haematologica 1996;81:208-15.
19. Gordon MY, Blackett NM. Some factors determining the minimum number of cells required for successful clinical engraftment. Bone Marrow Transplant 1995;15:659-62.
20. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995;13:2547-55.
21. Haas R, Möhle R, Frühauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787-94.
22. Schwella N, Beyer J, Schwaner I, et al. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol 1996;4:1114-21.
23. Leibundgut K, von Rohr A, Brülhart K, et al. The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children. Bone Marrow Transplant 1995;15:25-31.
24. Bensinger WI, Longin K, Appelbaum F, et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-GSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994;87:825-31.
25. Jones HM, Jones SA, Watts MJ, et al. Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol 1994;12:1693-702.
26. Zimmerman TM, Lee WJ, Bender JG, et al. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant 1995;15;439-44.
27. Kiss JE, Rybka WB, Winkelstein A, et al. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997;19:303-10.
28. Serke S, Watts M, Knudsen LM, et al. In-vitro clonogenicity of mobilized peripheral blood CD34-expressing cells: inverse correlation to both relative and absolute numbers of CD34-expresing cells. Br J Haematol 1996;95:234-40.